GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Ingevity Corp (FRA:IGX) » Definitions » Long-Term Capital Lease Obligation

Ingevity (FRA:IGX) Long-Term Capital Lease Obligation : €31 Mil (As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is Ingevity Long-Term Capital Lease Obligation?

Ingevity's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was €31 Mil.

Ingevity's quarterly Long-Term Capital Lease Obligation declined from Sep. 2024 (€36 Mil) to Dec. 2024 (€35 Mil) and declined from Dec. 2024 (€35 Mil) to Mar. 2025 (€31 Mil).

Ingevity's annual Long-Term Capital Lease Obligation increased from Dec. 2022 (€39 Mil) to Dec. 2023 (€45 Mil) but then declined from Dec. 2023 (€45 Mil) to Dec. 2024 (€35 Mil).


Ingevity Long-Term Capital Lease Obligation Historical Data

The historical data trend for Ingevity's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ingevity Long-Term Capital Lease Obligation Chart

Ingevity Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Long-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.52 32.04 38.52 44.57 35.14

Ingevity Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Long-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.40 38.93 35.86 35.14 30.80

Ingevity  (FRA:IGX) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Ingevity Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Ingevity's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Ingevity Business Description

Industry
Traded in Other Exchanges
Address
4920 O\'Hear Avenue, Suite 400, North Charleston, SC, USA, 29405
Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The Company generates the majority of its revenue from North America.

Ingevity Headlines

No Headlines